IHE icon

iShares US Pharmaceuticals ETF

149 hedge funds and large institutions have $345M invested in iShares US Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 21 closing their positions.

Holders
149
Holders Change
-6
Holders Change %
-3.87%
% of All Funds
2.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
34
Reduced
43
Closed
21
Calls
$212K
Puts
Net Calls
+$212K
Net Calls Change
+$205K
Name Market Value Shares Shares
Change
Shares
Change %
Two Sigma Investments
151
Two Sigma Investments
New York
-67,400 Closed
PCA
152
Pallas Capital Advisors
Massachusetts
-58,258 Closed
GC
153
Grimes & Company
Massachusetts
-14,715 Closed
IWC
154
Integrated Wealth Concepts
Massachusetts
-13,931 Closed
OPS
155
Orion Portfolio Solutions
Nebraska
-10,465 Closed
BCI
156
Brinker Capital Investments
Pennsylvania
-10,465 Closed
CRI
157
Commonwealth Retirement Investments
Virginia
-8,157 Closed
ST
158
Sabal Trust
Florida
-7,461 Closed
D.E. Shaw & Co
159
D.E. Shaw & Co
New York
-6,040 Closed
WG
160
Welch Group
Alabama
-4,358 Closed
Wealth Enhancement Advisory Services
161
Wealth Enhancement Advisory Services
Minnesota
-4,298 Closed
SP
162
Stonebrook Private
Michigan
-4,219 Closed
SC
163
Scotia Capital
Ontario, Canada
-4,123 Closed
SS
164
Sunbelt Securities
Texas
-3,702 Closed
CIBC World Market
165
CIBC World Market
Ontario, Canada
-3,215 Closed
CFGS
166
Concourse Financial Group Securities
Alabama
-168 Closed
SPIA
167
Steward Partners Investment Advisory
New York
-162 Closed
MA
168
Modus Advisors
Minnesota
-99 Closed
RFG
169
REAP Financial Group
Texas
-63 Closed
BTI
170
Blue Trust Inc
Georgia
-23 Closed
FFA
171
Farther Finance Advisors
California
-14 Closed